SIRNA THERAPEUTICS AND TARGETED GENETICS FORM HUNTINGTON'S DISEASE COLLABORATION

Sirna Therapeutics and Targeted Genetics have established a collaboration to develop a novel therapy for the treatment of Huntington's Disease (HD), an incurable neurodegenerative disorder. The collaboration significantly advances Sirna's HD program by using Targeted Genetics' adeno-associated virus (AAV) delivery platform to develop an HD product.

Yahoo News (http://biz.yahoo.com/prnews/050111/latu034_1.html)